Advancing Wilson Disease Care: Evolving Approaches for Copper Control - Episode 2
Neurological and Psychiatric Manifestations in Wilson Disease
Panelists discuss the often misdiagnosed neurological and psychiatric manifestations of Wilson disease, highlighting its overlap with common movement and mental health disorders, the need for high clinical suspicion, and the importance of early diagnosis through careful evaluation of overlapping symptoms.
In this episode, 'Neurological and Psychiatric Manifestations in Wilson Disease,' the panelists explore the complex and often nonspecific neurological and psychiatric landscape of Wilson disease. Dr. Peter Hedera describes the condition as a "great imitator" because it frequently mimics more common movement disorders such as Parkinson's disease, dystonia, and essential tremor. This clinical overlap often leads to significant diagnostic delays, sometimes lasting two years or longer. The experts stress that a high index of suspicion is required for any patient under the age of 40 or 50 presenting with unexplained movement symptoms.
The discussion also delves into the psychiatric side of the disease, noting that approximately 10% of patients may present with psychosis. This can create a diagnostic trap where neuroleptic treatments for psychiatric symptoms cause extrapyramidal side effects that further mask the underlying Wilson disease. In pediatric populations, the panelists shift the focus to neuropsychiatric indicators, such as sudden changes in school performance, cognitive shifts, or hyperkinetic movements like chorea.
Finally, the panel addresses the overlap between hepatic and neurological symptoms. While adults frequently show signs of both, pediatric patients under age 10 rarely exhibit neurological symptoms. However, that frequency increases to roughly 30% in adolescents. The experts conclude that while the coexistence of elevated liver enzymes and movement disorders is a major red flag, clinicians must rely on thorough laboratory confirmation to navigate these overlapping clinical presentations and ensure the best patient outcomes through early diagnosis.
The next episode in this series, 'Understanding Pathophysiology and Copper Transport in Wilson Disease,' features the panelists advancing their conversation on Wilson disease and focusing on the genetic and cellular mechanisms of the condition. Dr. Peter Hedera explains how mutations in the ATP7B gene disrupt copper homeostasis, leading to toxic accumulation in the liver and brain.
